KR900013961A - 기억력 및 학습력 증강 또는 인식 또는 정신장해 치료용 d-시클로세린 및 d-알라닌 함유 조성물 - Google Patents
기억력 및 학습력 증강 또는 인식 또는 정신장해 치료용 d-시클로세린 및 d-알라닌 함유 조성물 Download PDFInfo
- Publication number
- KR900013961A KR900013961A KR1019900003482A KR900003482A KR900013961A KR 900013961 A KR900013961 A KR 900013961A KR 1019900003482 A KR1019900003482 A KR 1019900003482A KR 900003482 A KR900003482 A KR 900003482A KR 900013961 A KR900013961 A KR 900013961A
- Authority
- KR
- South Korea
- Prior art keywords
- therapeutically effective
- effective amount
- alanine
- cycloserine
- ratio
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Hydrogenated Pyridines (AREA)
- Macromonomer-Based Addition Polymer (AREA)
- Detergent Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US32427989A | 1989-03-15 | 1989-03-15 | |
| US324,279 | 1989-03-25 | ||
| US473,241 | 1990-02-06 | ||
| US07/473,241 US5061721A (en) | 1989-03-15 | 1990-02-06 | Composition containing d-cycloserine and d-alanine for memory and learning enhancement or treatment of a cognitive or psychotic disorder |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR900013961A true KR900013961A (ko) | 1990-10-22 |
Family
ID=26984373
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1019900003482A Ceased KR900013961A (ko) | 1989-03-15 | 1990-03-15 | 기억력 및 학습력 증강 또는 인식 또는 정신장해 치료용 d-시클로세린 및 d-알라닌 함유 조성물 |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US5061721A (cg-RX-API-DMAC7.html) |
| EP (1) | EP0387867B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2963720B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR900013961A (cg-RX-API-DMAC7.html) |
| AT (1) | ATE88890T1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU624917B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2010635C (cg-RX-API-DMAC7.html) |
| DE (1) | DE69001503T2 (cg-RX-API-DMAC7.html) |
| DK (1) | DK0387867T3 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2055197T3 (cg-RX-API-DMAC7.html) |
| FI (1) | FI901289A7 (cg-RX-API-DMAC7.html) |
| GR (1) | GR3008225T3 (cg-RX-API-DMAC7.html) |
| IE (1) | IE64130B1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL93562A (cg-RX-API-DMAC7.html) |
| NO (1) | NO901198L (cg-RX-API-DMAC7.html) |
| NZ (1) | NZ232809A (cg-RX-API-DMAC7.html) |
| PT (1) | PT93424B (cg-RX-API-DMAC7.html) |
Families Citing this family (61)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5153193A (en) * | 1991-10-01 | 1992-10-06 | Hoechst-Roussel Pharmaceuticals Incorporated | Carbamate derivatives of 4-amino-3-isoxazolidinones, 3-amino-1-hydroxypyrrolidin-2-ones and 1-amino-1-cyclopropanecarboxylic acid analogs |
| US5854217A (en) * | 1992-09-28 | 1998-12-29 | Bearsden Bio, Inc. | Allosteric modulators of the NMDA receptor and their use in the treatment of CNS disorders and enhancement of CNS function |
| JPH07505908A (ja) * | 1992-09-28 | 1995-06-29 | マックセチーニ、マリア ルイザ | Nmda受容体のアロステリックモジュレーター |
| US5302609A (en) * | 1992-12-16 | 1994-04-12 | The Regents Of The University Of Michigan | Treatment of diabetic nephropathy |
| US20040208875A1 (en) | 1995-03-15 | 2004-10-21 | Queen's University At Kingston | Method for treating amyloidosis |
| EP0691844A1 (en) * | 1993-03-29 | 1996-01-17 | Queen's University At Kingston | Method for treating amyloidosis |
| US5523323A (en) * | 1993-09-14 | 1996-06-04 | Maccecchini; Maria-Luisa | Use of partial agonists of the NMDA receptor to reduce opiate induced tolerance and dependence |
| AU4019395A (en) * | 1994-11-23 | 1996-06-17 | G.D. Searle & Co. | Use of amino-isoxazolidone compounds for improvement of implicit memory |
| ATE204852T1 (de) * | 1995-02-15 | 2001-09-15 | Bearsden Bio Inc | Alkylcarboxy-aminosäure modulatoren für den kainat-rezeptor |
| JP2002513380A (ja) | 1996-07-22 | 2002-05-08 | コグネティックス・インコーポレイテッド | コナントキンの使用 |
| US6515103B1 (en) | 1996-07-22 | 2003-02-04 | University Of Utah Research Foundation | Conantokins |
| US6277825B1 (en) | 1996-07-22 | 2001-08-21 | University Of Utah Research Foundation | Use of conantokins for treating pain |
| AU765603C (en) * | 1998-04-14 | 2004-08-05 | General Hospital Corporation, The | Methods for treating neuropsychiatric disorders |
| US6551993B1 (en) * | 1999-08-16 | 2003-04-22 | Thomas Jefferson University | Partial agonists at the glycine modulatory site of the NMDA receptor for treating cognitive dysfunction |
| US6399574B1 (en) | 2000-03-22 | 2002-06-04 | University Of Utah Research Foundation | Use of conantokins |
| US20040122090A1 (en) * | 2001-12-07 | 2004-06-24 | Lipton Stuart A. | Methods for treating neuropsychiatric disorders with nmda receptor antagonists |
| ATE519485T1 (de) * | 2001-03-29 | 2011-08-15 | Michael Davis | Akute pharmakologische verstärkung einer psychotherapie mit d-cycloserine |
| US20050096396A1 (en) * | 2002-03-28 | 2005-05-05 | Emory University | Acute pharmacologic augmentation of psychotherapy with enhancers of learning or conditioning |
| CN1527813A (zh) | 2001-04-02 | 2004-09-08 | О | 作为治疗剂的抗氧化剂硝基氧和亚硝氮碳基 |
| WO2002087423A2 (en) * | 2001-05-02 | 2002-11-07 | Blanchette Rockefeller Neurosciences Institute | Carbonic anhydrase activators for enhancing learning and memory |
| US20050176826A1 (en) * | 2002-03-15 | 2005-08-11 | H. Lundbeck A/S | Use of asc-1 inhibitors to treat neurological and psychiatric disorders |
| UA80055C2 (en) * | 2003-05-27 | 2007-08-10 | Forest Laboratories | Combination of nmda-receptor antagonist and selective inhibitor of serotonin reuptake for a depression and other pscihiatric disorders treatment |
| US7414076B2 (en) | 2003-06-23 | 2008-08-19 | Neurochem (International) Limited | Methods and compositions for treating amyloid-related diseases |
| US7244764B2 (en) | 2003-06-23 | 2007-07-17 | Neurochem (International) Limited | Methods and compositions for treating amyloid-related diseases |
| US20070010573A1 (en) | 2003-06-23 | 2007-01-11 | Xianqi Kong | Methods and compositions for treating amyloid-related diseases |
| EP1660634A4 (en) * | 2003-08-08 | 2009-02-18 | Burnham Inst | P16-mediated regulation of NMDA receptors |
| KR20070007276A (ko) | 2003-12-29 | 2007-01-15 | 제이슨 맥데빗 | 재발성 의학적 증상을 치료하기 위한 조성물 및 방법 |
| TW201207390A (en) | 2004-05-18 | 2012-02-16 | Brni Neurosciences Inst | Method for screening agent for antidepressant activity |
| US8058291B2 (en) | 2005-04-06 | 2011-11-15 | Adamas Pharmaceuticals, Inc. | Methods and compositions for the treatment of CNS-related conditions |
| US7619007B2 (en) * | 2004-11-23 | 2009-11-17 | Adamas Pharmaceuticals, Inc. | Method and composition for administering an NMDA receptor antagonist to a subject |
| EP1836161B1 (en) | 2004-12-22 | 2016-07-20 | BHI Limited Partnership | Methods and compositions for treating amyloid-related diseases |
| TW200716088A (en) | 2005-04-15 | 2007-05-01 | Neurochem Int Ltd | Formulations and methods for treating amyloidosis |
| SI2089417T1 (sl) | 2006-10-12 | 2015-04-30 | Bhi Limited Partnership | Metode, spojine, sestavki in vektorji za dostavo 3-amino-1-propansulfonske kisline |
| US20100113453A1 (en) * | 2007-04-10 | 2010-05-06 | Mcdevitt Jason P | Sublingual Formulations of D-Cycloserine and Methods of Using Same |
| MX2011003015A (es) | 2008-09-18 | 2011-11-18 | Univ Northwestern | Moduladores del receptor de n-metil-d-aspartato, y usos de los mismos. |
| US20100216805A1 (en) | 2009-02-25 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis using d-cycloserine combinations |
| US8951968B2 (en) | 2009-10-05 | 2015-02-10 | Northwestern University | Methods of treating depression and other related diseases |
| TWI544923B (zh) * | 2009-12-29 | 2016-08-11 | 何應瑞 | 用於治療神經退化性疾病之醫藥組合物 |
| SG10201501050RA (en) | 2010-02-11 | 2015-04-29 | Univ Northwestern | Secondary Structure Stabilized NMDA Receptor Modulators And Uses Thereof |
| KR101692275B1 (ko) | 2010-02-11 | 2017-01-04 | 노오쓰웨스턴 유니버시티 | 2차 구조 안정화된 nmda 수용체 조절제 및 그의 용도 |
| JP5689026B2 (ja) * | 2010-06-17 | 2015-03-25 | 株式会社 資生堂 | 水中油型乳化皮膚化粧料 |
| US9789093B2 (en) * | 2011-01-31 | 2017-10-17 | Serotech, Llc | Dosage regimen, medication dispensing package and uses thereof for the treatment of major depressive disorder |
| US9737562B2 (en) | 2012-12-11 | 2017-08-22 | The Mclean Hospital Corporation | Xenon and/or argon treatment as an adjunct to psychotherapy for psychiatric disorders |
| WO2014120784A1 (en) | 2013-01-29 | 2014-08-07 | Naurex, Inc. | Spiro-lactam nmda receptor modulators and uses thereof |
| SG11201505937SA (en) | 2013-01-29 | 2015-09-29 | Naurex Inc | Spiro-lactam nmda receptor modulators and uses thereof |
| JP6419087B2 (ja) | 2013-01-29 | 2018-11-07 | アプティニックス インコーポレイテッド | スピロラクタム系nmda受容体モジュレーターおよびその使用 |
| CN105308049A (zh) | 2013-01-29 | 2016-02-03 | 阿普廷伊克斯股份有限公司 | 螺-内酰胺nmda受体调节剂及其用途 |
| CA2898861C (en) | 2013-01-29 | 2021-07-20 | Naurex, Inc. | Spiro-lactam nmda receptor modulators and uses thereof |
| US9877951B2 (en) | 2015-02-12 | 2018-01-30 | College Of William And Mary | Method for treating dementia |
| WO2017201285A1 (en) | 2016-05-19 | 2017-11-23 | Aptinyx Inc. | Spiro-lactam nmda receptor modulators and uses thereof |
| PE20190174A1 (es) | 2016-05-19 | 2019-02-01 | Aptinyx Inc | Moduladores del receptor espiro-lactama n-metil-d-aspartato y usos de los mismos |
| JP2019527235A (ja) | 2016-08-01 | 2019-09-26 | アプティニックス インコーポレイテッド | スピロ−ラクタム及びビス−スピロ−ラクタムnmda受容体修飾因子及びその使用 |
| EP3490992B1 (en) | 2016-08-01 | 2023-03-22 | Aptinyx Inc. | Spiro-lactam nmda receptor modulators and uses thereof |
| PE20190501A1 (es) | 2016-08-01 | 2019-04-10 | Aptinyx Inc | Moduladores nmda espiro-lactam y metodos de uso de los mismos |
| CN109890825B (zh) | 2016-08-01 | 2022-03-11 | 阿普廷伊克斯股份有限公司 | 螺-内酰胺nmda受体调节剂及其用途 |
| CA3031534C (en) | 2016-08-01 | 2023-10-17 | Aptinyx Inc. | Spiro-lactam nmda receptor modulators and uses thereof |
| EP3427729A1 (en) | 2017-07-13 | 2019-01-16 | Paris Sciences et Lettres - Quartier Latin | Probenecid for use in treating epileptic diseases, disorders or conditions |
| PE20210455A1 (es) | 2018-01-31 | 2021-03-08 | Aptinyx Inc | Moduladores del receptor nmda espiro-lactama y usos de los mismos |
| WO2020252384A1 (en) * | 2019-06-14 | 2020-12-17 | Vorsanger Gary | Treatment methods utilizing oxytocin receptor agonists |
| US12012413B2 (en) | 2019-11-11 | 2024-06-18 | Tenacia Biotechnology (Hong Kong) Co., Limited | Methods of treating painful diabetic peripheral neuropathy |
| KR102287477B1 (ko) * | 2019-11-27 | 2021-08-09 | (주)뉴로라이브 | 우울증 치료를 위한 사이클로세린 및 리튬 병용 요법 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3428730A (en) * | 1967-06-30 | 1969-02-18 | Hamao Umezawa | Antibacterial mixture of o-carbamyl-d-serine and d-4-amino-3-isoxazolidone |
| US4031231A (en) * | 1974-06-13 | 1977-06-21 | Merck & Co., Inc. | Antibacterial composition comprising 3-fluoro-D-alanine or deutero analog in combination with auto-antagonist inhibitor |
| US4904681A (en) * | 1987-12-01 | 1990-02-27 | G. D. Searle & Co. | D-cycloserine and its prodrugs as cognitive enhancers |
-
1990
- 1990-02-06 US US07/473,241 patent/US5061721A/en not_active Expired - Lifetime
- 1990-02-27 IL IL9356290A patent/IL93562A/en active IP Right Grant
- 1990-03-06 AU AU50734/90A patent/AU624917B2/en not_active Ceased
- 1990-03-06 NZ NZ232809A patent/NZ232809A/en unknown
- 1990-03-14 JP JP2063937A patent/JP2963720B2/ja not_active Expired - Lifetime
- 1990-03-14 IE IE92190A patent/IE64130B1/en not_active IP Right Cessation
- 1990-03-14 CA CA002010635A patent/CA2010635C/en not_active Expired - Fee Related
- 1990-03-14 PT PT93424A patent/PT93424B/pt not_active IP Right Cessation
- 1990-03-14 NO NO90901198A patent/NO901198L/no unknown
- 1990-03-15 KR KR1019900003482A patent/KR900013961A/ko not_active Ceased
- 1990-03-15 AT AT90104875T patent/ATE88890T1/de not_active IP Right Cessation
- 1990-03-15 FI FI901289A patent/FI901289A7/fi not_active IP Right Cessation
- 1990-03-15 DK DK90104875.1T patent/DK0387867T3/da active
- 1990-03-15 ES ES90104875T patent/ES2055197T3/es not_active Expired - Lifetime
- 1990-03-15 EP EP90104875A patent/EP0387867B1/en not_active Expired - Lifetime
- 1990-03-15 DE DE9090104875T patent/DE69001503T2/de not_active Expired - Fee Related
-
1993
- 1993-06-18 GR GR930400134T patent/GR3008225T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0387867A1 (en) | 1990-09-19 |
| PT93424B (pt) | 1996-08-30 |
| ATE88890T1 (de) | 1993-05-15 |
| IL93562A (en) | 1996-01-31 |
| DE69001503T2 (de) | 1993-09-09 |
| AU624917B2 (en) | 1992-06-25 |
| CA2010635A1 (en) | 1990-09-15 |
| FI901289A0 (fi) | 1990-03-15 |
| NO901198D0 (no) | 1990-03-14 |
| NZ232809A (en) | 1992-05-26 |
| PT93424A (pt) | 1990-11-07 |
| FI901289A7 (fi) | 1990-09-16 |
| IE64130B1 (en) | 1995-07-12 |
| US5061721A (en) | 1991-10-29 |
| GR3008225T3 (cg-RX-API-DMAC7.html) | 1993-09-30 |
| EP0387867B1 (en) | 1993-05-05 |
| JP2963720B2 (ja) | 1999-10-18 |
| NO901198L (no) | 1990-09-17 |
| DK0387867T3 (da) | 1993-06-01 |
| IL93562A0 (en) | 1990-11-29 |
| JPH03148221A (ja) | 1991-06-25 |
| DE69001503D1 (de) | 1993-06-09 |
| CA2010635C (en) | 2001-03-06 |
| IE900921L (en) | 1990-09-15 |
| AU5073490A (en) | 1990-09-20 |
| ES2055197T3 (es) | 1994-08-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE419858T1 (de) | Krillextrakte zur prävention und/oder behandlung von herz-kreislauf-erkrankungen | |
| ATE219674T1 (de) | Zusammensetzung enthaltend capsaicin oder seine analogen und lokalanästhetika | |
| CA2339221A1 (en) | Extracts of feverfew (tanacetum parthenium) against inflammatory disorders | |
| DE69533940D1 (de) | Therapeutische zusammensetzungen von venösdilatoren und arterielldilatoren | |
| KR950002785A (ko) | 골량을 증가시키기 위한 부갑상선 호르몬 및 랄옥시펜 | |
| ATE270111T1 (de) | Zusammensetzung und methode zur reduktion der toxizität von biologisch-aktiven faktoren | |
| KR940018089A (ko) | 내부조직의 방사선 손상에 대한 예방 및 처치방법 | |
| ES2160643T3 (es) | Composiciones que contienen g-csf y proteina de union al tnf. | |
| KR950007848A (ko) | (S)-(-)-α-에틸-2-옥소-1-피롤리딘아세트아미드를 사용한 불안치료방법 | |
| RU94002133A (ru) | 6-хлор-5-фтор-3-(2-теноил)-2-оксиндол-1-карбоксамид как аналгезирующее и противовоспалительное средство | |
| ES2136167T3 (es) | Composiciones de idebenona para tratar la enfermedad de alzheimer. | |
| RU94037555A (ru) | Железосодержащая композиция для предотвращения анемии, способ ее изготовления и способ лечения анемии | |
| BR9809678A (pt) | Derivados de triptolìdeo úteis no tratamento de doenças autoimunes | |
| BRPI0409699A (pt) | métodos de indução do efeito diurético, de indução, manutenção ou restauração do efeito diurético de diurético não modificador de adenosina, de manutenção, restauração ou melhoria da função renal em paciente, de indução de diurese, de prevenção do inìcio de deficiência renal em paciente com sobrecarga de fluidos ou chf, de tratamento de paciente que sofre de chf e de melhoria dos resultados globais da saúde, composição farmacêutica e seus usos | |
| IL101675A (en) | Method and pharmaceutical compositions for detecting and localizing tissues having neurokinine 1 receptors | |
| RU93048600A (ru) | Натуральный поливитаминный комплекс "леветон" | |
| RU95102611A (ru) | Способ лечения туберкулеза легких | |
| KR880004810A (ko) | 소화성 궤양 치료제 | |
| PE20040932A1 (es) | Metodo de mejora de la circulacion sanguinea | |
| KR890015746A (ko) | 메게스트롤 아세테이트로 aids 악액질을 치료하는 방법 | |
| KR900017599A (ko) | 종양 치료용 약학 조성물 | |
| EA200200559A1 (ru) | Способ лечения и профилактики нейродегенеративных состояний | |
| RU93018067A (ru) | Способ лечения кавернозной формы туберкулеза | |
| RU95122262A (ru) | Способ лечения повреждений периферических нервов при травмах конечностей | |
| RU95102346A (ru) | Способ лечения дисциркуляторной энцефалопатии |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 19900315 |
|
| PG1501 | Laying open of application | ||
| A201 | Request for examination | ||
| PA0201 | Request for examination |
Patent event code: PA02012R01D Patent event date: 19950315 Comment text: Request for Examination of Application Patent event code: PA02011R01I Patent event date: 19900315 Comment text: Patent Application |
|
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 19980213 Patent event code: PE09021S01D |
|
| E601 | Decision to refuse application | ||
| PE0601 | Decision on rejection of patent |
Patent event date: 19980506 Comment text: Decision to Refuse Application Patent event code: PE06012S01D Patent event date: 19980213 Comment text: Notification of reason for refusal Patent event code: PE06011S01I |